Akèy › Kansè Endomèt › Oklahoma › Tulsa
Etid klinik pou Kansè Endomèt nan Tulsa, OK
3 etid pou Kansè Endomèt ap chèche patisipan nan sit nan ak bò kote Tulsa (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Ap rekriteFaz 3
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6047), Tulsa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Tulsa
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Ap rekriteFaz 2/3
- Oklahoma Cancer Specialists and Research Institute, Tulsa
Etid Kansè Endomèt nan lòt vil
- Houston, TX68 etid
- New York City, NY52 etid
- Boston, MA50 etid
- Arlington, VA39 etid
- Nashville, TN38 etid
- Los Angeles, CA34 etid
- St. Louis, MO29 etid
- Philadelphia, PA28 etid
- San Antonio, TX27 etid
- Chicago, IL25 etid
- Columbus, OH25 etid
- Queens, NY25 etid
Lòt etid nan Tulsa
- Ensifizyans kadyak10 etid
- Sipwa6 etid
- Obèsite5 etid
- Melanom5 etid
- Akidan serebral iskemi5 etid
- BPCO4 etid
- Maladi Parkinson4 etid
- Stenoz valv aòt4 etid
- Kansè kol4 etid
- Kansè nan tete4 etid
- Kansè Poumon ki pa ti selil4 etid
- Kansè ovè4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.